SITAGLIPTIN PHOSPHATE (sitagliptin phosphate)


Drug overview for SITAGLIPTIN PHOSPHATE (sitagliptin phosphate):

Generic name: SITAGLIPTIN PHOSPHATE (sit-a-GLIP-tin)
Drug class: Antihyperglycemic-dipeptidyl peptidase-4 (DPP-4) Inhibitors
Therapeutic class: Endocrine

Sitagliptin phosphate, a dipeptidyl peptidase-4 (DPP-4) inhibitor, is an antidiabetic agent.

No enhanced Uses information available for this drug.
DRUG IMAGES
  • SITAGLIPTIN PHOSPHATE 25 MG TB
    SITAGLIPTIN PHOSPHATE 25 MG TB
  • SITAGLIPTIN PHOSPHATE 50 MG TB
    SITAGLIPTIN PHOSPHATE 50 MG TB
  • SITAGLIPTIN PHOS 100 MG TABLET
    SITAGLIPTIN PHOS 100 MG TABLET
The following indications for SITAGLIPTIN PHOSPHATE (sitagliptin phosphate) have been approved by the FDA:

Indications:
Type 2 diabetes mellitus


Professional Synonyms:
Adult onset diabetes mellitus
Adult onset diabetes
Adult onset DM
Diabetes mellitus type 2
Diabetes mellitus type II
Ketosis-resistant diabetes mellitus
Ketosis-resistant DM
Maturity onset diabetes mellitus
Maturity onset diabetes
Non-insulin dependent diabetes mellitus
Non-insulin-dependent diabetes mellitus
Type II diabetes mellitus